Health ❯ Healthcare ❯ Pharmaceuticals

Clinical Research

Weight Loss Drugs Peer-Reviewed Studies EASD Annual Meeting Cleveland Clinic Study Trial Results FDA Regulations Epidemiology Patient Outcomes Novo Nordisk Eledon Pharmaceuticals Phase 3 Trials Pharmacokinetics Phase I/II Studies Osteogenesis Imperfecta Cancer Treatment Weight Loss Medications Ophthalmology Phase III Trials Hormonal Treatments Ethics in Research Lōkahi Therapeutics Retatrutide

10 ARTICLES

2mo ago

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

Regulators cited a head-to-head trial that showed about an 8% relative drop in major heart events versus Lilly’s older drug Trulicity, prompting wider use for high-risk adults with type 2 diabetes.

4 ARTICLES

4mo ago

House Select Committee Opens National-Security Inquiries Into Merck and AbbVie China Trials

9 ARTICLES

6mo ago

Kailera Leaps 62% in Nasdaq Debut After $625 Million IPO

5 ARTICLES

7mo ago

Artelo Secures Fully Funded Investigator-Led Glaucoma Trial With Belfast Health Trust

3 ARTICLES

11mo ago

EMA Panel Backs Higher 7.2 mg Wegovy Dose for Obesity

3 ARTICLES

11mo ago

FDA Accepts Sonrotoclax NDA, Grants Priority Review for Relapsed Mantle Cell Lymphoma

9 ARTICLES

last yr.

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use